PHARMACEUTICALS DERMATOLOGICAL INDICATIONS

Brand Owner (click to sort) Address Description
DERMAVANT DERMAVANT SCIENCES GMBH Viaduktstrasse 8 Basel 4051 Switzerland Pharmaceuticals for dermatological indications;
DERMAVANT DERMAVANT SCIENCES LTD. 2 CHURCH STREET CLARENDON HOUSE HAMILTON HM 11 Bermuda Pharmaceuticals for dermatological indications;
DERMAVANT Roivant Dermatology Ltd. Clarendon House 2 Church Street Hamilton HM11 Bermuda Pharmaceuticals for dermatological indications;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is directed to a prevention and treatment for dermatological disorders. One aspect of this invention involves a dermatological treatment comprising one or more polypeptides with an amino acid sequence including KPV (SEQ. ID. NO. 1), MEHFRWGKPV (SEQ. ID. NO. 2), HFRWGKPV (SEQ. ID. NO. 3), or SYSMEHFRWGKPV (SEQ. ID. NO. 4) for the treatment and prevention of dermatological disorders. The polypeptides are at a level to effectively treat the cutaneous inflammation and are carried by a carrier. The one or more polypeptides can also be a dimer formed from any of the amino acid sequence above.